Is COVID the Rx for the Pharmaceutical Industry’s Reputation?

Astra-Zeneca, BioNTech, Clinical Trials, COVID-19, COVID-19 Healthcare Marketing, COVIG-19 Alliance, Darlene Dobry, global public health crisis, Greedy pharma, GSK, Healthcare Advertising Agency, Healthcare Marketing Agency, healthcare reform, healthcare success, IFPMA, International Federation of Pharmaceutical Manufacturers and Associations, Johnson & Johnson, Kevzara, Medical Advertising Agency, Moderna, mRNA, mRNA vaccine, Novavax, Pharma indrustry, pharma marketing, pharma/device marketing and advertising, Pharmaceutical Marketing, Pharmaceutical Research and Manufacturers of America, PhRMA, Regeneron, remdesivir, Sanofi, Takeda, Thomas Cueni / August 26, 2020

Darlene Dobry, Strategic Advisor, Medical Devices and Pharmaceuticals As the COVID-19 pandemic continues to bring the world’s economies, healthcare systems, and communities to their knees, the Pharma industry appears to be the shining hope to help us return to a new normal. Could the industry’s response to this global public health crisis be the Rx …

Is COVID the Rx for the Pharmaceutical Industry’s Reputation? Read More »